Login
$CNTN
$1.93 +$0.02 (1.05%) Pre-market

$CNTN SEC Filings

Filed On Filing
27 Oct 2026 Form 4: Wendland Mark Paul, Director

Granted 1,031,821 Restricted Stock Units

27 Oct 2026 Form 4: Toomey Mark Christopher, President

Granted 928,639 Restricted Stock Units

27 Oct 2026 Form 4: Wiley William Thomas Jr., Director

Granted 53,763 Stock Option (Right to Buy)

27 Oct 2026 Form 4: Galvin Sean, Director

Granted 53,763 Stock Option (Right to Buy)

27 Oct 2026 Form 4: Nangalia Rishi, Director

Granted 53,763 Stock Option (Right to Buy)

27 Oct 2026 Form 4: Carter Pamela L, Director

Granted 53,763 Stock Option (Right to Buy)

27 Oct 2026 Form 4: Kahler Thomas Clay, Director

Granted 53,763 Stock Option (Right to Buy)

27 Oct 2026 Form 4: Sommers Jill E., Director

Granted 53,763 Stock Option (Right to Buy)

27 Oct 2026 SCHEDULE 13G
14 Aug 2026 8-K: Results of Operations and Financial Condition
14 Aug 2026 10-Q
23 Jul 2026 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
17 Jul 2026 8-K: Submission of Matters to a Vote of Security Holders; Other Events
15 Jul 2026 Form 3: Nangalia Rishi, Director

No securities owned

15 Jul 2026 Form 3: Carter Pamela L, Director

No securities owned

15 Jul 2026 Form 3: Galvin Sean, Director

No securities owned

08 Jul 2026 SCHEDULE 13G/A
25 Jun 2026 Proxy statement: annual meeting on July 13, 2026
16 Jun 2026 8-K: Regulation FD Disclosure; Other Events
27 May 2026 Form 4: Stetz Gary S., Director

Sold 87,851 shares ($301K) · Sold 12,500 shares ($43.4K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support